about
p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration.Ethyl Acetate Extract of Origanum vulgare L. ssp. hirtum Prevents Streptozotocin-Induced Diabetes in C57BL/6 Mice.The critical role of macrophage migration inhibitory factor in insulin activity.Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects.Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity.Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic isletsAnti-diabetic actions of carbon monoxide-releasing molecule (CORM)-A1: Immunomodulation and regeneration of islet beta cells.Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice.Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro.Methanolic extract of Origanum vulgare ameliorates type 1 diabetes through antioxidant, anti-inflammatory and anti-apoptotic activity.Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents.Novel octahedral Pt(IV) complex with di-n-propyl-(S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoato ligand exerts potent immunomodulatory effects.p38α blocks brown adipose tissue thermogenesis through p38δ inhibitionCarbon Monoxide-Releasing Molecule-A1 Inhibits Th1/Th17 and Stimulates Th2 DifferentiationIn vitro
P50
Q36635737-8AA1AAF1-CA12-4382-9B05-1B6BE5D2D936Q38863031-6D4BF299-453D-407F-8593-3A22DF9B39C5Q38975490-A439D1AC-64B1-47C3-BED3-4408DE191659Q38981079-5BF969B2-E83A-41EB-B32A-B5613230CE9FQ39027987-0EAA64A6-1D8F-40C9-B0A0-1244309E3B3EQ39270465-CDF0CA3E-F876-4932-A8B5-640C898DCE8AQ40944709-78A818DC-87CE-41C6-808D-579507EF6C45Q41118998-A50517ED-5937-4AC0-9F4F-2AA6EDB4BEDAQ42030632-1C778465-1D74-4CF3-B9D5-784397524715Q44879308-173EB920-9B26-46EC-98A4-E276F88623FEQ46774147-F4BD2FBE-D1C8-4873-8B6E-B6670BBC223EQ51443240-26B5A052-E0E4-43E3-A78C-392F2539F91CQ55462745-73CAA6E8-6B36-4D4B-AFA3-BB9599C52055Q58326138-8957EE9E-8547-421A-973A-4D612D6718F4Q59089917-43008C94-8EAF-4AE0-85D0-50C6560F53C3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ivana Nikolić
@ast
Ivana Nikolić
@en
Ivana Nikolić
@es
Ivana Nikolić
@nl
type
label
Ivana Nikolić
@ast
Ivana Nikolić
@en
Ivana Nikolić
@es
Ivana Nikolić
@nl
prefLabel
Ivana Nikolić
@ast
Ivana Nikolić
@en
Ivana Nikolić
@es
Ivana Nikolić
@nl
P106
P1153
53985161200
57093369400
P31
P496
0000-0003-2879-8563